Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands

Recent discoveries in molecular diagnostics and drug treatments have improved the treatment of patients with advanced (inoperable) non-squamous non-small cell lung cancer (NSCLC) from solely platinum-based chemotherapy to more personalized treatment, including targeted therapies and immunotherapies....

Descripción completa

Detalles Bibliográficos
Autores principales: Mfumbilwa, Zakile A., Wilschut, Janneke A., Simons, Martijn J. H. G., Ramaekers, Bram, Joore, Manuela, Retèl, Valesca, der Welle, Christine M. Cramer-van, Schramel, Franz M. N. H., van de Garde, Ewoudt M. W., Coupé, Veerle M. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911639/
https://www.ncbi.nlm.nih.gov/pubmed/36759641
http://dx.doi.org/10.1038/s41598-023-29286-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911639/
https://www.ncbi.nlm.nih.gov/pubmed/36759641
http://dx.doi.org/10.1038/s41598-023-29286-5

Ejemplares similares